PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsInsulin human isophane
Insulin human isophane
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
183 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13101343821104
Type 2 diabetes mellitusD003924EFO_0001360E115519481894
Type 1 diabetes mellitusD003922EFO_0001359E104209639
Insulin resistanceD007333EFO_0002614E88.819139518
HyperglycemiaD006943R73.91128113
Gestational diabetesD016640O24.4333312
HypoglycemiaD007003E16.21214
StrokeD020521EFO_0000712I63.91112
Body weightD001835EFO_000433811
Weight gainD01543011
Show 16 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pregnancy in diabeticsD011254O24.911113
HypertensionD006973EFO_0000537I10112
Cardiovascular diseasesD002318EFO_0000319I9811
HypercholesterolemiaD00693711
Coronary diseaseD00332711
AtherosclerosisD050197EFO_0003914I25.111
OverweightD050177E66.311
Body weight changesD00183611
AsthmaD001249EFO_0000270J4511
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
Show 9 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TherapeuticsD01381211
Oxidative stressD018384EFO_100190511
PregnancyD011247EFO_0002950Z33.111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients44
LymphomaD008223C85.911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Heart disease risk factorsD00008274211
InflammationD007249MP_000184511
HemostasisD00648711
Glucose intoleranceD018149HP_0000833R73.0311
Fetal macrosomiaD00532011
Fatty liverD005234EFO_000393411
Kidney transplantationD01603011
Pregnancy complicationsD01124811
PharmacokineticsD01059911
Therapeutic equivalencyD01381011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
850 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use